PCT & Men’s Fitness Medications

This category covers hormone-modulating medicines such as oestrogen blockers and aromatase inhibitors. They are licensed cancer and fertility treatments that are sometimes used after anabolic steroid cycles, which is an unlicensed and risky practice.

Medicines in the Pct & Men's Fitness category

Clomid

Clomifene

25 · 50 · 100mg

Utilized for reproductive health support, this medicine is indicated to address ovulatory disorders and designed to support natural conception.

From $0.53 / tablet View

Serophene

Clomifene

25 · 50 · 100mg

Developed to support fertility in women and indicated to target the endocrine system for improved ovulatory function.

From $0.39 / tablet View

Nolvadex

Tamoxifen

10 · 20mg

Formulated to manage hormone-receptor-positive breast cancer and to support treatment outcomes through oestrogen receptor inhibition.

From $0.32 / tablet View

Arimidex

Anastrozole

1mg

Arimidex is developed to target hormone-dependent breast cancer and is formulated to alleviate tumour progression.

From $2.34 / tablet View

Armotraz

Anastrozole

1mg

Indicated to help manage oestrogen-dependent conditions by supporting the suppression of excess hormone production in postmenopausal patients.

From $3.11 / tablet View

Femara

Letrozole

2.5mg

Femara is indicated for the treatment of hormone-dependent breast cancer and utilized to alleviate tumour growth in post-menopausal women.

From $0.51 / tablet View

Aromasin

Exemestane

25mg

Developed to target oestrogen production and indicated to support cancer treatment, this inhibitor is utilized to address hormone-sensitive malignancies.

From $4.73 / tablet View

What’s in this category

SERMs such as clomifene and tamoxifen influence oestrogen signalling.
Aromatase inhibitors like anastrozole, letrozole and exemestane lower oestrogen.

Conditions it covers

These medicines are licensed for breast cancer and anovulatory infertility.

PCT & Men’s Fitness in Asia

Interest in fitness and body composition has grown fast across Asia’s cities, and with it, demand for the hormone-modulating medicines covered here. These are licensed cancer and fertility treatments, so using them well outside those settings benefits from informed, professional input.